Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. BR112012010661 - método para tratar insuficiência cardíaca com peptídeos semelhantes à estressecopina

Office
Brésil
Numéro de la demande 112012010661
Date de la demande 04.11.2010
Numéro de publication 112012010661
Date de publication 22.11.2016
Type de publication A2
CIB
A61K 38/00
ANÉCESSITÉS COURANTES DE LA VIE
61SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
KPRÉPARATIONS À USAGE MÉDICAL, DENTAIRE OU POUR LA TOILETTE
38Préparations médicinales contenant des peptides
CPC
A61K 38/2228
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
2228Corticotropin releasing factor [CRF] (Urotensin)
A61P 3/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
A61P 9/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Déposants Janssen Pharmaceutica N.V
Inventeurs Hani S. Sabbah
Nigel P. Shankley
Peter J. Genco
Mandataires Dannemann ,Siemsen, Bigler & Ipanema Moreira
Données relatives à la priorité 12612548 04.11.2009 US
61/258,181 04.11.2009 US
Titre
(PT) método para tratar insuficiência cardíaca com peptídeos semelhantes à estressecopina
Abrégé
(PT)
método para tratar insuficiência cardíaca com peptídeos semelhantes à estressecopina. a presente invenção refere-se a métodos inovadores de tratamento de insuficiência cardíaca, que compreende administrar uma quantidade de peptídeo semelhante à estressecopina a um indivíduo que precisa do mesmo; e substancialmente manter a quantidade do dito peptídeo presente no plasma do dito indivíduo em uma concentração resultante em um benefício terapâutico sem um aumento substancial na taxa cardíaca do dito indivíduo. o método envolve o uso de peptídeos semelhantes à estressecopina que são agonistas seletivos do receptor tipo 2 do hormônio liberador de corticotrofina (crhr2).

Related patent documents
NI2012-000085 IThis application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
CO12090200This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
UAa201206780This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.